Department of Fisheries Microbiology, Karnataka Veterinary, Animal & Fisheries Sciences University, College of Fisheries, Mangalore 575002, India.
Section of Aquatic Medicine and Nutrition, Department of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Adamstuen Campus, Ullevålseveien 72, P.O. Box 8146, NO-0033 Dep, Oslo 0454, Norway.
Vaccines (Basel). 2016 Jun 1;4(2):21. doi: 10.3390/vaccines4020021.
Aeromonas hydrophila is a Gram-negative bacterium that causes high mortality in different fish species and at different growth stages. Although vaccination has significantly contributed to the decline of disease outbreaks in aquaculture, the use of oral vaccines has lagged behind the injectable vaccines due to lack of proven efficacy, that being from primary immunization or by use of boost protocols. In this study, the outer membrane protein W (OmpW) of A. hydrophila was cloned, purified, and encapsulated in poly d,l-lactide-co-glycolic acid (PLGA) nanoparticles (NPs) for oral vaccination of rohu (Labeo rohita Hamilton). The physical properties of PLGA NPs encapsulating the recombinant OmpW (rOmpW) was characterized as having a diameter of 370-375 nm, encapsulation efficiency of 53% and -19.3 mV zeta potential. In vitro release of rOmpW was estimated at 34% within 48 h of incubation in phosphate-buffered saline. To evaluate the efficacy of the NP-rOmpW oral vaccine, two antigen doses were orally administered in rohu with a high antigen (HiAg) dose that had twice the amount of antigens compared to the low antigen (LoAg) dose. Antibody levels obtained after vaccination showed an antigen dose dependency in which fish from the HiAg group had higher antibody levels than those from the LoAg group. The antibody levels corresponded with post challenge survival proportions (PCSPs) and relative percent survival (RPS) in which the HiAg group had a higher PCSP and RPS than the LoAg group. Likewise, the ability to inhibit A. hydrophila growth on trypticase soy agar (TSA) by sera obtained from the HiAg group was higher than that from the LoAg group. Overall, data presented here shows that OmpW orally administered using PLGA NPs is protective against A. hydrophila infection with the level of protective immunity induced by oral vaccination being antigen dose-dependent. Future studies should seek to optimize the antigen dose and duration of oral immunization in rohu in order to induce the highest protection in vaccinated fish.
嗜水气单胞菌是一种革兰氏阴性细菌,可导致不同鱼类品种和不同生长阶段的高死亡率。尽管疫苗接种极大地减少了水产养殖中的疾病爆发,但由于缺乏经过验证的功效,口服疫苗的使用落后于注射疫苗,无论是从初次免疫还是使用加强免疫方案。在这项研究中,嗜水气单胞菌的外膜蛋白 W(OmpW)被克隆、纯化并封装在聚丙交酯-乙交酯(PLGA)纳米颗粒(NPs)中,用于罗非鱼(Labeo rohita Hamilton)的口服疫苗接种。封装重组 OmpW(rOmpW)的 PLGA NPs 的物理性质具有 370-375nm 的直径、53%的包封效率和-19.3mV 的 zeta 电位。在磷酸盐缓冲盐水孵育 48 小时内,rOmpW 的体外释放估计为 34%。为了评估 NP-rOmpW 口服疫苗的功效,在罗非鱼中口服给予两种抗原剂量,高抗原(HiAg)剂量的抗原量是低抗原(LoAg)剂量的两倍。接种后获得的抗体水平显示出与抗原剂量的依赖性,其中 HiAg 组的鱼比 LoAg 组的鱼具有更高的抗体水平。抗体水平与攻毒后存活比例(PCSP)和相对存活率(RPS)相对应,其中 HiAg 组的 PCSP 和 RPS 高于 LoAg 组。同样,来自 HiAg 组的血清抑制胰蛋白酶大豆琼脂(TSA)上嗜水气单胞菌生长的能力高于来自 LoAg 组的血清。总的来说,这里呈现的数据表明,使用 PLGA NPs 口服给予 OmpW 可预防嗜水气单胞菌感染,口服疫苗诱导的保护免疫水平与抗原剂量有关。未来的研究应寻求优化罗非鱼的抗原剂量和口服免疫持续时间,以在接种鱼类中诱导最高的保护。